Suppr超能文献

健康成年人接种黄热病病毒疫苗后中和抗体的持久性。

Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults.

机构信息

Scientific Department, Army Medical Center, Rome, Italy.

Scientific Department, Army Medical Center, Rome, Italy.

出版信息

Vaccine. 2023 Apr 24;41(17):2761-2763. doi: 10.1016/j.vaccine.2023.03.022. Epub 2023 Mar 24.

Abstract

In accordance with the World Health Organization, one dose of yellow fever vaccine may guarantee protection lifelong in healthy adults. However, relatively little information is still available from ad hoc studies. We evaluated the persistence of neutralizing antibodies, which are considered to be an immune correlate of protection, in a large number of military personnel vaccinated up to 47 years before. Overall, 322 individuals were studied. The median time from vaccination to blood collection for neutralizing antibody evaluation was 9 years, ranging from <1 to 47 years. Of the 322 participants, 319 had neutralizing antibodies (99.1 %). The highest median PRNT value was observed in those vaccinated ≤1 year before (median PRNT = 320). In conclusion, our study confirms on a larger scale that, in healthy adults, neutralizing antibodies may persist as long as 47 years after a single yellow fever vaccines dose.

摘要

根据世界卫生组织的规定,一剂黄热病疫苗可在健康成年人中提供终身保护。然而,来自特别研究的信息仍然相对较少。我们评估了大量接种疫苗长达 47 年前的军人的中和抗体的持久性,这些抗体被认为是保护的免疫相关物。总共研究了 322 个人。从接种疫苗到采集血液以评估中和抗体的中位数时间为 9 年,范围从<1 年到 47 年。在 322 名参与者中,有 319 人具有中和抗体(99.1%)。在接种疫苗≤1 年前观察到的最高中位数 PRNT 值(中位数 PRNT=320)。总之,我们的研究在更大范围内证实,在健康成年人中,单次黄热病疫苗接种后,中和抗体可能会持续长达 47 年。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验